Cargando…
Chinese medicinal plants for the potential management of high-altitude pulmonary oedema and pulmonary hypertension
CONTEXT: Despite the abundance of knowledge regarding high-altitude pulmonary edoema (HAPE) and high-altitude pulmonary hypertension (HAPH), their prevalence continues to be on the rise. Thus, there is an urgent need for newer safe, effective, and relatively economic drug candidates. China is partic...
Autores principales: | Wang, Tingting, Hou, Jun, Xiao, Wenjing, Zhang, Yaolei, Zhou, Longfu, Yuan, Li, Yin, Xiaoqiang, Chen, Xin, Hu, Yonghe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641673/ https://www.ncbi.nlm.nih.gov/pubmed/32883127 http://dx.doi.org/10.1080/13880209.2020.1804407 |
Ejemplares similares
-
High-altitude pulmonary oedema: Newer treatment modalities for an age-old problem
por: Yanamandra, Uday, et al.
Publicado: (2019) -
Lower Respiratory Tract Infection: An Unrecognised Risk Factor for High Altitude Pulmonary Oedema?
por: Humphries, Christopher P.
Publicado: (2017) -
Deregulated hypoxic response in myeloid cells: A model for high‐altitude pulmonary oedema (HAPE)
por: Gojkovic, Milos, et al.
Publicado: (2020) -
Pseudo-pulmonary oedema
por: Paliwal, Bharat, et al.
Publicado: (2014) -
KGF-2 targets alveolar epithelia and capillary endothelia to reduce high altitude pulmonary oedema in rats
por: She, Jun, et al.
Publicado: (2012)